| Variable | Pharmacotherapy group (noECT, n = 19) | Bilateral ECT group (B-ECT, n = 19) | Between-group differences | ||
| Age (years) | 47.2 (12.0) | 47.8 (12.3) | t(36) = 0.16, p = 0.87 | ||
| Sex (% female) | 52.6 | 52.6 | χ2 (1, n = 38) < 0.001, p = 1.00 | ||
| Educational level* (% 1 - 2 - 3 - 4) | 0% - 36.8% - 53.6% - 10.5% | 10.5% - 47.4% - 26.3% - 15.8% | χ2 (3, n = 38) = 4.12, p = 0.25 | ||
| NART IQ | 113.1 (7.1) | 110.2 (8.9) | t(32) = 1.06, p = 0.30 | ||
| Pre-Treatment HRSD-24 | 31.2 (6.1) | 29.4 (5.7) | t(36) = 0.91, p = 0.37 | ||
| Post-Treatment HRSD-24 | 19.0 (9.5) | 15.6 (9.3) | t(36) = 1.11, p = 0.28 | ||
| Follow-Up HRSD-24 | 19.5 (10.0) | 16.4 (9.8) | t(36) = 0.99, p = 0.33 | ||
| CAMI-SF Semantic component |
|
| |||
| Pre-Treatment | 14.61 (4.3) | 13.97 (3.8) | F(1, 36) = 1.87, p = 0.18 | ||
| Post-Treatment | 13.47 (4.1) | 11.13 (3.6) | |||
| Follow-Up | 13.53 (4.2) | 11.32 (4.0) | |||
| CAMI-SF Episodic-Extended component |
|
| |||
| Pre-Treatment | 12.63 (4.0) | 12.03 (3.5) | F(1, 36) = 2.09, p = 0.16 | ||
| Post-Treatment | 10.03 (3.8) | 8.34 (2.9) | |||
| Follow-Up | 9.53 (3.3) | 7.42 (2.9) | |||
| CAMI-SF Episodic-Specific component |
|
| |||
| Pre-Treatment | 14.87 (9.2) | 12.95 (5.8) | F(1, 36) = 4.43, p = 0.042 | ||
| Post-Treatment | 10.26 (7.8) | 4.82 (3.7) | |||
| Follow-Up | 8.32 (6.7) | 3.76 (3.4) | |||